Clinical Signs Assessment Dataset in Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-abdominal Infections
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
Documentation of clinical signs including vital signs, results of C-reactive protein and blood gases, seizure activity, urine output, cardioactive drugs received, and abdominal radiography Study Description An open-label, multiple-dose study to determine the safety, tolerability, and pharmacokinetics of meropenem in preterm and term infants less than 91 days of age with suspected or confirmed intra-abdominal infections. Biospecimens are available. Infants less than 91 days of age with suspected or confirmed intra-abdominal infection
创建时间：
2022-06-03
